688739 Liaoning Chengda Biotechnology

Watchlist

26.27
-0.18-0.68%

Market Closed Dec 25 15:00 CST

10.94BMarket Cap32.96P/E (TTM)

Liaoning Chengda Biotechnology Key Stats

According to the latest financial report of Liaoning Chengda Biotechnology, the latest earnings per share (TTM) for the company is 0.80. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

BVPS

Analyzing a company's fundamentals? Check out Liaoning Chengda Biotechnology's latest financial report to see how much their book value per share (BVPS) is currently at 22.93.

Currency: CNY

Cumulative Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Liaoning Chengda Biotechnology shows that the company's current ratio is 18.62, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Liaoning Chengda Biotechnology, the quick ratio is 17.44, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

ROE

Want to learn more about the financial health of Liaoning Chengda Biotechnology? The latest ROE figure is 3.44%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Liaoning Chengda Biotechnology, the total asset return on investment (ROA) is 3.28%.

Currency: CNY

Cumulative Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Liaoning Chengda Biotechnology's latest financial report to see how their gross margin is doing - currently at 82.92%.

Currency: CNY

Cumulative Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Liaoning Chengda Biotechnology, the net profit margin is 25.31%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Top CN Stock Gainers

Symbol Price % Chg

Zhejiang Tongxing Technology

301252

35.14 +20.01%

Dongguan Dingtong Precision Metal Co.,Ltd.

688668

51.24 +20.00%

Hangzhou Shenhao Technology

300853

26.76 +20.00%

Zhejiang Changsheng Sliding Bearings